{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T21:36:58Z","timestamp":1789940218063,"version":"4.0.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2005,2,4]],"date-time":"2005-02-04T00:00:00Z","timestamp":1107475200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2005,4]]},"DOI":"10.1007\/s00277-004-0977-1","type":"journal-article","created":{"date-parts":[[2005,2,3]],"date-time":"2005-02-03T17:22:27Z","timestamp":1107451347000},"page":"250-257","source":"Crossref","is-referenced-by-count":50,"title":["Conventional cytogenetics of myeloproliferative diseases other than CML contribute valid information"],"prefix":"10.1007","volume":"84","author":[{"given":"Ulrike","family":"Bacher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torsten","family":"Haferlach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Kern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Hiddemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Schnittger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Schoch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,2,4]]},"reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S0889-8588(03)00087-X","volume":"17","author":"A Adewale","year":"2003","unstructured":"Adewale A, Gordon D (2003) Cytogenetics of chronic myeloproliferative disorders and related myelodysplastic syndromes. Hematol Oncol Clin North Am 17:1129?1149","journal-title":"Hematol Oncol Clin North Am"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1053\/beha.2001.0153","volume":"14","author":"AJ Bench","year":"2001","unstructured":"Bench AJ, Cross NCP, Huntly BJP, Nacheva EP, Green AR (2001) Myeloproliferative disorders. Best Pract 14:531?551","journal-title":"Best Pract"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1056\/NEJMoa025217","volume":"348","author":"J Cools","year":"2003","unstructured":"Cools J, DeAngelo DJ, Gotlib J, Stover EH, Legare RD, Cortes J, Kutok J, Clark J, Galinsky I, Griffin JD, Cross NCP, Tefferi A, Malone J, Alam R, Schrier SL, Schmid J, Rose M, Vandenberghe P, Verhoef G, Boogaerts M, Wlodarska I, Kantarjian H, Marynen P, Coutre SE, Stone R, Gilliland DG (2003) A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med 348:1201?1214","journal-title":"N Engl J Med"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.semcancer.2003.11.004","volume":"14","author":"S Coutre","year":"2004","unstructured":"Coutre S, Gotlib J (2004) Targeted treatment of hypereosinophilic syndromes and chronic eosinophilic leukemias with imatinib mesylate. Semin Cancer Biol 14:23?31","journal-title":"Semin Cancer Biol"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/sj.leu.2402556","volume":"16","author":"NCP Cross","year":"2002","unstructured":"Cross NCP, Reiter A (2002) Tyrosine kinase fusion genes in chronic myeloproliferative diseases. Leukemia 16:1207?1212","journal-title":"Leukemia"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMra020777","volume":"349","author":"JM Goldman","year":"2003","unstructured":"Goldman JM, Melo JV (2003) Mechanisms of disease?chronic myeloid leukemia?advances in biology and new approaches to treatment. N Engl J Med 349:1451?1464","journal-title":"N Engl J Med"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0165-4608(86)90197-4","volume":"21","author":"Groupe Fran\u00e7ais de Cytog\u00e9n\u00e9tique H\u00e9matologique","year":"1986","unstructured":"Groupe Fran\u00e7ais de Cytog\u00e9n\u00e9tique H\u00e9matologique (1986) Cytogenetics of chronic myelomonocytic leukemia. Cancer Genet Cytogenet 21:11?30","journal-title":"Cancer Genet Cytogenet"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0165-4608(01)00410-1","volume":"128","author":"Y Herishanu","year":"2001","unstructured":"Herishanu Y, Lishner M, Bomstein Y, Kitay-Cohen Y, Fejgin MD, Gaber E, Amiel A (2001) Comparative genomic hybridization in polycythemia vera and essential thrombocytosis patients. Cancer Genet Cytogenet 128:154?157","journal-title":"Cancer Genet Cytogenet"},{"key":"CR9","volume-title":"Tumours of haematopoietic and lymphoid tissues","author":"E Jaffe","year":"2001","unstructured":"Jaffe E, Lee Harris, Stein H, Vardiman JW (2001) Tumours of haematopoietic and lymphoid tissues. IARC, Lyon"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1159\/000046636","volume":"107","author":"B Johansson","year":"2002","unstructured":"Johansson B, Fioretos T, Mitelman F (2002) Cytogenetic and molecular genetic evolution of chronic myeloid leukemia. Acta Haematol 107:76?94","journal-title":"Acta Haematol"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1182\/blood-2003-03-0919","volume":"102","author":"S Klippel","year":"2003","unstructured":"Klippel S, Strunck E, Temerinac S, Bench AJ, Meinhardt G, Mohr U, Leichtle R, Green AR, Griesshammer M, Heimpel H, Pahl HL (2003) Quantification of PRV-1 mRNA distinguishes polycythemia vera from secondary erythrocytosis. Blood 102:3569?3574","journal-title":"Blood"},{"key":"CR12","first-page":"214","volume":"5","author":"F Mertens","year":"1991","unstructured":"Mertens F, Johansson B, Heim S, Kristoffersson U, Mitelman F (1991) Karyotypic patterns in chronic myeloproliferative disorders?report on 74 cases and review of the literature. Leukemia 5:214?220","journal-title":"Leukemia"},{"key":"CR13","unstructured":"Mitelman F (1995) An International System for Human Cytogenetic Nomenclature (1995): Recommendations of the International Standing Committee on Human Cytogenetic Nomenclature, Memphis, Tennessee, October 1994"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1056\/NEJMra035363","volume":"350","author":"AI Schafer","year":"2004","unstructured":"Schafer AI (2004) Current concepts?thrombocytosis. N Engl J Med 350:1211?1219","journal-title":"N Engl J Med"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/sj.leu.2402813","volume":"17","author":"C Schoch","year":"2003","unstructured":"Schoch C, Haferlach T, Kern W, Schnittger S, Berger U, Hehlmann R, Hiddemann W, Hochaus A (2003) Occurrence of additional chromosome aberrations in chronic myeloid leukemia patients treated with imatinib mesylate. Leukemia 17:461?463","journal-title":"Leukemia"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/sj.leu.2402329","volume":"16","author":"C Schoch","year":"2002","unstructured":"Schoch C, Schnittger S, Bursch S, Gerstner D, Hochhaus A, Berger U, Hehlmann R, Hiddemann W, Haferlach T (2002) Comparison of chromosome banding analysis, interphase- and hypermetaphase-FISH, qualitative and quantitative PCR for diagnosis and for follow-up in chronic myeloid leukemia: a study on 350 cases. Leukemia 16:53?59","journal-title":"Leukemia"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0165-4608(89)90127-1","volume":"43","author":"M Sessarego","year":"1989","unstructured":"Sessarego M, Defferrari R, Dejana AM, Rebuttato AM, Fugazza G, Salvidio E, Ajmar F (1989) Cytogenetic analysis in essential thrombocythemia at diagnosis and at transformation?a 12-year study. Cancer Genet Cytogenet 43:57?65","journal-title":"Cancer Genet Cytogenet"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1056\/NEJM200004273421706","volume":"342","author":"A Tefferi","year":"2000","unstructured":"Tefferi A (2000) Medical progress: myelofibrosis with myeloid metaplasia. N Engl J Med 342:1255?1265","journal-title":"N Engl J Med"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1182\/blood-2003-10-3505","volume":"103","author":"A Tefferi","year":"2004","unstructured":"Tefferi A, Lasho TL, Wolanskyj AP, Mesa RA (2004) Neutrophil PRV-1 expression across the chronic myeloproliferative disorders and in secondary or spurious polycythemia. Blood 103:3547?3548","journal-title":"Blood"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1046\/j.1365-2141.2001.03131.x","volume":"115","author":"A Tefferi","year":"2001","unstructured":"Tefferi A, Meyer RG, Wyatt WA, Dewald GW (2001) Comparison of peripheral blood interphase cytogenetics with bone marrow karyotype analysis in myelofibrosis with myeloid metaplasia. Br J Haematol 115:316?319","journal-title":"Br J Haematol"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s00277-002-0604-y","volume":"82","author":"J Thiele","year":"2003","unstructured":"Thiele J, Kvasnicka HM (2003) Chronic myeloproliferative disorders with thrombocythemia: a comparative study of two classification systems (PVSG, WHO) on 839 patients. Ann Hematol 82:148?152","journal-title":"Ann Hematol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-004-0977-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-004-0977-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-004-0977-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,21]],"date-time":"2024-01-21T22:20:35Z","timestamp":1705875635000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-004-0977-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2,4]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["977"],"URL":"https:\/\/doi.org\/10.1007\/s00277-004-0977-1","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,2,4]]}}}